Traumatic brain injury. Diffuse traumatic brain injury
Conditions
Interventions
Intervention 1: Intervention group: Inflawell receiving group, 3 month, 3 times/day, Oral Administration (400 mg), Boswellic acids powder in KondorPharma Pharmaceutical Company (Canada), was encapsula
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: traumatic brain injury patients Patients who are in 3 months to 3 years from the time of traumatic brain injury
Exclusion criteria
Exclusion criteria: Patients with uncontrollable seizures Patients with impaired level of consciousness Patients with (Glasgo outcome scale) GOS less than 3 Taking anticholinergic drugs Taking anticonvulsants and sedatives drugs (such as Phenytoin, Topiramate, Levetiracetam) Epidural hematoma, subdural hematoma and Contusion substance abuse Previous brain trauma Multiple sclerosis, Bipolar mood disorder, Schizophrenia, aphasia, spinal cord injury, motor disorder Lactation and pregnanacy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive impairment intensity. Timepoint: At the commencement of the investigation and after taking Inflawell capsules. Method of measurement: Rey Auditory Verbal Learning Test-Recognition Test (AVLT-R), Wechsler adult intelligence Digit Symbol Substitution Test (DSST) and trail-making test part B (TMT-B). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVajihe Aghamolie
Tehran University of Medical Sciences
Outcome results
None listed